574-575 / 1816
Tailoring risk factors
•
Subtype, margin involvement
extent (focal or gross), planned
adjuvant therapy.
•
Are we at the stage where we
can tailor our decisions?
•
Probably not yet
•
Most studies have excluded
grossly positive margins and
recruitment to trials would be
challenging